Rmb Capital Management, LLC Galapagos Nv Transaction History

Rmb Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$96.85 - $148.25 $516,307 - $790,320	-5,331 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$185.52 - $231.25 $224,293 - $279,581	-1,209 Reduced 18.49%	5,331 $1.05 Million
Q1 2020 May 11, 2020	SELL	$143.0 - $274.03 $1.11 Million - $2.13 Million	-7,784 Reduced 54.34%	6,540 $1.28 Million
Q4 2019 Feb 13, 2020	SELL	$146.12 - $215.82 $113,973 - $168,339	-780 Reduced 5.16%	14,324 $2.96 Million
Q3 2019 Nov 12, 2019	BUY	$130.44 - $187.64 $1.97 Million - $2.83 Million	15,104 New	15,104 $2.31 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.76B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.